טוען...
Treatment of 5 dogs with immune-mediated thrombocytopenia using Romiplostim
BACKGROUND: Immune thrombocytopenia (ITP) in dogs is analogous to that in humans. Romiplostim, a novel thrombopoietin receptor (TPO-R) agonist, is currently used for the treatment of refractory ITP in humans, but not in dogs. Here, we describe the response to romiplostim in five dogs with refractory...
שמור ב:
| הוצא לאור ב: | BMC Vet Res |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4901510/ https://ncbi.nlm.nih.gov/pubmed/27283401 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12917-016-0718-4 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|